Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy

被引:102
|
作者
Langendijk, JA
Slotman, BJ
van der Waal, I
Doornaert, P
Berkof, J
Leemans, CR
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Maxillary Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
关键词
head and neck carcinoma; radiotherapy; prognostic factors; overall treatment time;
D O I
10.1002/cncr.21340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to define different prognostic groups with regard to locoregional control (LRC) derived from recursive partitioning analysis (RPA). METHODS. Eight hundred one patients with squamous cell head and neck carcinoma underwent with primary surgery and received postoperative radiotherapy. For the definition of prognostic groups, the method of classification and regression trees was performed, including a large number of well known prognostic factors. RESULTS. The final model was composed of six prognostic factors for LRC, resulting in seven terminal nodes. RPA Class I (intermediate risk) consisted of 381 patients who had no N3 lymph nodes, free surgical margins (> 5 mm), and no extranodal spread (ENS). RPA Class 11 (high risk) consisted of 189 patients who had 1 positive lymph node with ENS or had T1, T2, or T4 tumors with close or positive surgical margins. RPA Class III (very high risk) consisted of 231 patients who had a N3 neck, 2 positive lymph nodes with ENS, or a T3 tumor with close or positive surgical margins. The 5-year LRC rate was 88%, 73% and 58%, in RPA Class 1, 11, and III, respectively (P < 0.0001). The hazard ratio (HR) relative to RPA Class I was 2.3 (95% confidence interval [95%CI], 1.5-3.6) for RPA Class II and 4.2 (95%CI, 2.8-6.1) for RPA Class III. CONCLUSIONS. The RPA classification scheme studied allowed for the clear definition of three prognostic groups with regard to LRC and OS. These groups may be useful in the design of future prospective, randomized studies investigating new treatment modalities.
引用
收藏
页码:1408 / 1417
页数:10
相关论文
共 50 条
  • [31] Elective neck dissection during salvage surgery after radiotherapy in patients with head and neck squamous cell carcinoma
    Pedemonte, G.
    Esteller, E.
    Villator, J-C
    Costa, J-M
    Valero, C.
    Quer, M.
    Leon, X.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2018, 38 (02) : 86 - 93
  • [32] Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
    Elbers, Joris B. W.
    Al-Mamgani, Abrahim
    van den Brekel, Michiel W. M.
    Jozwiak, Katarzyna
    de Boer, J. P.
    Lohuis, Peter J. F. M.
    Willems, Stefan M.
    Verheij, Marcel
    Zuur, Charlotte L.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2019, 160 (06) : 1023 - 1033
  • [33] Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck
    Langendijk, Johannes A.
    Ferlito, Alfio
    Takes, Robert P.
    Rodrigo, Juan P.
    Suarez, Carl
    Strojan, Primo
    Haigentz, Missak, Jr.
    Rinaldo, Alessandra
    ORAL ONCOLOGY, 2010, 46 (08) : 577 - 585
  • [34] Recursive partitioning analysis of 2105 patients treated in radiation therapy oncology group studies of head and neck cancer
    Cooper, JS
    Farnan, NC
    Asbell, SO
    Rotman, M
    Marcial, V
    Fu, KK
    McKenna, WG
    Emami, B
    CANCER, 1996, 77 (09) : 1905 - 1911
  • [35] PRE VERSUS POSTOPERATIVE RADIOTHERAPY OF RESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    WENNERBERG, J
    ACTA OTO-LARYNGOLOGICA, 1995, 115 (04) : 465 - 474
  • [36] Survival analysis of patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed radiotherapy and immunotherapy
    Xu, Peng
    Liu, Dongmei
    Zhou, Jie
    Tang, Zhengyi
    Wang, Shuo
    Huang, Yecai
    Feng, Mei
    Lu, Shun
    Lang, Jinyi
    Orlandini, Lucia Clara
    RADIATION ONCOLOGY, 2025, 20 (01)
  • [37] Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
    Wang, Lei
    Pang, Wenjing
    Zhou, Kun
    Li, Lei
    Wang, Feng
    Cao, Wei
    Meng, Xiangjun
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [38] Patterns of failure for recurrent head and neck squamous cell carcinoma treated with salvage surgery and postoperative IMRT reirradiation
    Mohamed, Abdallah S. R.
    Martin, Geoffrey V.
    Ng, Sweet Ping
    Takiar, Vinita
    Beadle, Beth M.
    Zafereo, Mark
    Garden, Adam S.
    Frank, Steven J.
    Fuller, C. David
    Gunn, G. Brandon
    Morrison, William H.
    Rosenthal, David I.
    Reddy, Jay
    Moreno, Amy
    Lee, Anna
    Phan, Jack
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 44
  • [39] Treatment of the no neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma
    Temam, S
    Koka, V
    Mamelle, G
    Julieron, M
    Carmantrant, R
    Marandas, P
    Janot, F
    Bourhis, J
    Luboinski, B
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (08): : 653 - 658
  • [40] THE INCIDENCE OF HYOPTHYROIDISM IN PATIENTS WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK TREATED WITH RADICAL RADIOTHERAPY AND CITUXIMAB
    Borg, M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S23 - S23